Efficacy, Immunogenicity, and Safety of High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age
Latest Information Update: 15 Apr 2022
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Sanofi Pasteur
- 05 Apr 2022 Status changed from recruiting to suspended.
- 15 Mar 2022 Planned End Date changed from 1 Jul 2024 to 1 Jul 2026.
- 15 Mar 2022 Planned primary completion date changed from 1 Jul 2024 to 1 Jul 2026.